Ledger.Open graph →

SEC Form D · Amendment · filed April 19, 2023

Enveric Biosciences, Inc

Offering

$12.8M

Sold

$12.8M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NAPLES, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Avani Kanubaddi · Naples, FLExec Michael D. Webb · Naples, FLDirector Marcus Schabacker · Naples, FLDirector George Kegler · Naples, FLDirector Frank Pasqualone · Naples, FLDirector Kevin Coveney · Naples, FLExec Mark Lee · New York, NYDirector Peter G. Wilson · London, United KingdomDirector Brian Blagg · Indianapolis, INDirector Genevieve Gilbreath · Austin, TXExec Carolina A. Espinal · London, United KingdomDirector Joseph Tucker · Beverly, MAExec · Director Bob Dagher · Naples, FLExec Douglas Lind · Memphis, TNDirector Peter Facchini · Naples, FLExec Bevin O'Neil · Raleigh, NCDirector Ronan Guilfoyle · George Town, Grand Cayman, Cayman IslandsExec Thomas J. Bartos · Independence, OHDirector Garrett E. Zdolshek · Independence, OHDirector Richard Grant · BATESVILLE, INDirector Bruce Rippe · BATESVILLE, INDirector Joseph Tucker · Beverly, MAExec · Director Bob Dagher · Naples, FLExec Douglas Lind · Memphis, TNDirector Peter Facchini · Naples, FLExec Bevin O'Neil · Naples, FLDirector Kevin Coveney · Naples, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗